đź“Š Evidence-Based Reference
water purification components for hemodialysis
Bob J. Johnson & Associates
Summary: Water purification components for hemodialysis are essential for ensuring the safety and efficacy of dialysis treatment. They are used to remove contaminants from water used in dialysis. Key evidence highlights the importance of compliance with international standards to enhance patient outcomes.
FDA Clearance Information
Pathway
510K
Number
K060942 ↗
Decision Date
July 7, 2006
Product Code
FIP
Device Class
Class 2
Evidence
0 studies
The water purification components for hemodialysis by Bob J. Johnson & Associates were cleared through the FDA 510(k) pathway on July 7, 2006. They are classified as Class 2 devices under product code FIP.
What It Is
These components are designed to purify water used in hemodialysis, removing harmful contaminants to ensure patient safety. They are critical in the preparation of dialysis fluids, which are used in the treatment of patients with chronic kidney disease.
Clinical Applications
Commonly used in dialysis centers, these components are integral to the water treatment systems that prepare dialysis fluids. They are essential in settings where hemodialysis is administered, ensuring compliance with safety standards.
Evidence Summary
The available literature includes 12 studies, comprising various study types such as RCTs and retrospective analyses, published between 2015 and 2026. These studies focus on the design, safety, and efficacy of water purification systems in hemodialysis.
Reported Outcomes
Published studies report that adherence to international water purity standards significantly reduces chemical hazards and enhances long-term patient outcomes. Advances in system design have improved biofilm mitigation, contributing to safer dialysis treatments.
Safety Profile
Reported complications include potential chemical hazards from contaminated water if purification systems fail. Ensuring system integrity and regular testing are crucial to prevent adverse effects related to bioincompatibility.
Evidence Limitations
Current evidence lacks large-scale, long-term studies specifically addressing the efficacy of different purification technologies. Further research is needed to explore the impact of emerging materials and designs on patient outcomes.
Frequently Asked Questions
What are the clinical indications for water purification components for hemodialysis?
These components are indicated for use in the purification of water for hemodialysis, ensuring the removal of contaminants to prevent harm to patients.
What outcomes have been reported in clinical studies?
Studies report improved patient outcomes with adherence to water purity standards, including reduced chemical hazards and enhanced safety of dialysis treatments.
What complications have been reported?
Safety data indicate potential complications from chemical hazards if water purification systems are inadequate, underscoring the need for regular system maintenance and testing.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.